Variant report
Variant | esv3384292 |
---|---|
Chromosome Location | chr1:186730322-186730904 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:186729559..186732303-chr1:186735721..186738700,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs202056837 | chr1:186730342-186730343 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75125155 | chr1:186730352-186730353 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs76255391 | chr1:186730360-186730361 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1883272 | chr1:186730382-186730383 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs11589346 | chr1:186730487-186730488 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553731492 | chr1:186730584-186730585 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs551156113 | chr1:186730629-186730630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs79878277 | chr1:186730651-186730652 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs12072772 | chr1:186730697-186730698 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573171803 | chr1:186730797-186730798 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs540538198 | chr1:186730798-186730799 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12072820 | chr1:186730810-186730811 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558854051 | chr1:186730827-186730828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs577000482 | chr1:186730847-186730848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372720412 | chr1:186730848-186730849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555634989 | chr1:186730868-186730869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs186653997 | chr1:186730869-186730870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 20688739 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21611746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 17393978 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Schizophrenia | 19197363 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17899364 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:186715600-186730800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr1:186722600-186730800 | Weak transcription | A549 | lung |
3 | chr1:186729000-186731000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
4 | chr1:186729200-186731200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
5 | chr1:186729600-186731600 | Enhancers | GM12878-XiMat | blood |
6 | chr1:186730000-186730400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr1:186730600-186734000 | Enhancers | Hela-S3 | cervix |
8 | chr1:186730800-186731000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
9 | chr1:186730800-186733200 | Enhancers | HUVEC | blood vessel |
10 | chr1:186730800-186733600 | Enhancers | A549 | lung |